Regenxbio (RGNX) Free Cash Flow (QoQ) (2015 - 2025)
Regenxbio (RGNX) Free Cash Flow (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn |
| 10 | Regenxbio | 504.90 Mn | 274.83 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.71% |
| Sep 30, 2025 | -26.30% |
| Jun 30, 2025 | -241.69% |
| Mar 31, 2025 | 204.20% |
| Dec 31, 2024 | 25.38% |
| Sep 30, 2024 | 2.66% |
| Jun 30, 2024 | 23.09% |
| Mar 31, 2024 | -84.64% |
| Dec 31, 2023 | 50.11% |
| Sep 30, 2023 | -52.24% |
| Jun 30, 2023 | 53.42% |
| Mar 31, 2023 | -129.12% |
| Dec 31, 2022 | 29.27% |
| Sep 30, 2022 | -5.26% |
| Jun 30, 2022 | 24.85% |
| Mar 31, 2022 | -116.36% |
| Dec 31, 2021 | 472.81% |
| Sep 30, 2021 | -216.03% |
| Jun 30, 2021 | 27.47% |
| Mar 31, 2021 | -524.04% |